FORSYTH - Key Persons
Job Titles:
- Vice President, Chief Innovation Officer, Henry Schein, Inc
Bruce Lieberthal serves as the Chief Innovation Officer for Henry Schein, Inc., reporting to Chris Pendergast, Henry Schein's Global Chief Technology Officer. In this role, he is at the nexus of evaluating hundreds of cutting edge solutions and technologies, advising the many medical and dental business units of Henry Schein on important emerging trends and helping connect the company's global sales, marketing and distribution capabilities with important new products that help its customers run better practices and deliver excellent patient care.
Previously, from 2009 until 2015, he was the Vice President, Emerging Technologies for Henry Schein, Inc., reporting to the president of Henry Schein's Global Practice Solutions Group. Bruce had oversight responsibility for Henry Schein Medical Systems (MicroMD) between 2011 and 2017 and currently leads Henry Schein One's DDX business. He led the ConnectDental team for two years, which initiated Henry Schein's digital dentistry initiatives, and worked closely with the Corporate Business Development Group advising on technology opportunities.
Bruce started, at Henry Schein, as the Director of Product Management to the leadership team in Utah when Discus Dental Software was acquired by Henry Schein, Inc. in May 2007 and was promoted, in 2008, to Vice-President of Product Management and Development, managing all of Henry Schein Practice Solutions' software lines and development teams.
He was the founder of Direct Vision Software, the General Manager of Discus Dental Software and has been a leader in dental technology for almost 35 years.
Bruce graduated SUNY Oneonta in 1979, majoring in Anthropology and Pre-dentistry and SUNY Buffalo's School of Dentistry in 1983, practiced dentistry for 14 years between 1984 and 1997, and brings much knowledge to the Henry Schein team.
Bruce currently serves on The Forsyth Institute's Patent Committee.
Job Titles:
- Corporate Secretary, General Counsel and Vice President of Technology Development
- Executive Responsible
Carline M. Durocher is the executive responsible for Forsyth's legal and compliance functions, including general corporate transactions, corporate governance, regulatory compliance, and risk management.
Prior to her legal career, Carline was a technology research analyst at AMR Research, which was acquired by Gartner. She advised senior executives on their technology initiatives across multiple industries, including energy and regulated industries, automotive and aerospace and defense. Carline also published reports on enterprise performance management, asset performance management, IT portfolio management and outsourcing strategies.
Carline received an A.B. from Dartmouth College and a J.D. from Boston College Law School. She also completed the General Management Program (GMP) at Harvard Business School and serves on the HBS Global Alumni Board.
Carline is the executive responsible for Forsyth's legal, compliance and risk functions and board governance. As the Vice President of Technology Development, she is also responsible for spearheading Forsyth's efforts to develop an oral health innovation ecosystem.
Job Titles:
- President and CEO, the Greater Boston Food Bank
Job Titles:
- Chief Scientific Officer and Executive Vice President of CorVista Health
Job Titles:
- Henry Schein 's Global Chief Technology Officer
Job Titles:
- Co - Founder and Managing Director of CareCapital Advisors Limited
- Co - Founder and Managing Partner of CareCapital Advisors Limited
Dai Feng is the co-founder and managing director of CareCapital Advisors Limited, a healthcare focused VC and growth investor managing a multi-billion portfolio of more than 50 healthcare technology and service companies, with a strong focus on dentistry.
Job Titles:
- Retired, Was a Vice - President, Global Oral Care, for the Colgate - Palmolive Company
Previously on the staff of several dental schools, Tony has lectured in the fields of pharmacology, periodontal disease and preventive dentistry. He is a leading expert in the fields of Clinical Dental Research and Global Dental Caries and has published over 200 scientific papers in major national and international journals. In addition, Tony has practiced dentistry privately and is a former staff member at St. Peter's Hospital in New Brunswick, New Jersey.
He has been a past president of the American Dental Association's Foundation and currently serves on other Boards, such as the Foundation of the University of Medicine and Dentistry of New Jersey and the National Foundation of Dentistry for the Handicapped.
Job Titles:
- Dentist, Pediatric Dental Associates of Brookline, P.C
Dr. John Ficarelli is board certified and practices Pediatric Dentistry at Pediatric Dental Associates of Brookline, P.C. As Director of Dentistry at the Massachusetts Hospital School, he maintains staff positions at Tufts Medical Center and the Franciscan Hospital for Children.
He is President and a founding board member of Project Stretch: Dentistry Reaching Out to Children, an international dental volunteer organization. John is a standing member of the American Dental Association, the Massachusetts Dental Society, the American Cleft Palate Association, the Academy of Dentistry for Persons with Disabilities, and the American Academy of Pediatric Dentistry. He is also a fellow of the International College of Dentists, the Academy of Dental Science, and the American College of Dentists. John received his dental and pediatric specialty training at Tufts University School of Dental Medicine and Boston Floating Hospital of New England Medical Center, and is a Diplomate of the American Board of Pediatric Dentistry.
Job Titles:
- Walter C. Guralnick Distinguished Professor
Job Titles:
- Chief Executive Officer
- Chief Scientific Officer
Dr. Wenyuan Shi was appointed Chief Executive Officer and Chief Scientific Officer of the Forsyth Institute on September 1, 2017. Before his appointment, Shi was the chairman and professor of Oral Biology at UCLA Schools of Dentistry as well as the Professor of Microbiology, Immunology and Molecular Genetics at UCLA School of Medicine for 20+ years.
Dr. Shi has been leading numerous NIH grants to use multidisciplinary approaches to study oral microbial pathogenesis with a specific focus on microbial biofilm, inter-species interaction and signal transduction. In addition, Dr. Shi's laboratory is actively involved in the development of next generation of diagnostic and therapeutic tools against oral microbial infections, including instant chairside detection of oral pathogens and peptide based targeted antimicrobial therapeutics. These translational research efforts have resulted in novel technologies that were licensed and developed by major pharmaceutical, dental and biotech companies. Dr. Shi is the founding scientist, former chief scientific officer and chairman of the scientific advisory board of C3J Therapeutics Inc., which is now called Armata Pharmaceuticals (https://www.armatapharma.com), listed on NYSE.
Job Titles:
- Chairman of the Board
- CEO of BlueHub Capital
Elyse Cherry is the CEO of BlueHub Capital, a national nonprofit community finance organization located in Roxbury, MA with a 35-year history of building healthy communities where low-income people live and work.
Elyse has been named one of 50 most influential Bostonians by the Boston Business Journal, one of the Top 100 LGBT Executives in the world by the Financial Times and OUTstanding, and one of 21 Leaders for the 21st Century by Women's eNews. In 2014, The White House named Elyse a Solar Champion of Change. She received Wellesley's Alumnae Achievement Award in 2017, and she received the Susan M. Love Award from Fenway Health in 2014. For the past seven years, The Boston Globe and The Commonwealth Institute have included BlueHub Capital as one of the Top 100 Women-Led Businesses in Massachusetts.
Elyse is a former partner at the law firm of Hale and Dorr (now WilmerHale) where her national transactional practice focused on multi-family and commercial real estate finance and development, affordable housing, and open space preservation.
Felicitas Bidlack joined Forsyth in 2003 and leverages her passion for interdisciplinary and team research to facilitate successful internal as well as external collaborations. With experience in research and mentoring Dr. Bidlack serves as Senior Science Officer and Chair of the Appointments and Promotions Committee to generate a creative environment and empower innovative research.
Job Titles:
- Chief, Endocrine Unit Physician, Department of Medicine Massachusetts General Hospital
Job Titles:
- Principal, Boston Marketing Advisors
Janet Kelly is a seasoned management consulting professional, offering her expertise based upon 20 years as a Marketing and Operations Executive.
Her wide-ranging experience includes: the development of strategic supplier sourcing relationships, design and implementation of outsourced marketing operations engagements, and fulfilling executive management roles within Fortune 100 clients.
She has also established and led a San Francisco-based direct marketing agency. Most recently, Janet founded Boston Marketing Advisors, a process engineering and marketing consulting firm focused on building and growing profitable organizations in start-up, outsourced and mature business environments.
Janet holds a BA from Wheaton College, Norton, MA.
Job Titles:
- Managing Director of Life Sciences for Hercules Capital
Janice Bourque is Managing Director of Life Sciences for Hercules Capital, a premier specialty finance company providing debt and equity to venture capital and private equity backed, and small cap public life science companies at all stages of development with $5.9 billion committed to over 350 life science, technology and renewable energy companies. Deals include BIND Bioscience, Brickell, Cempra Pharmaceuticals, Concert Pharmaceutical, Cranford Pharmaceuticals, Dance Pharmaceuticals, deCode Genetics, Gamma Medica, Glori Energy, Medrobotics, Metuchen Pharmaceuticals, Ninepoint Medical and Pulmatrix.
Previously, Janice provided strategic corporate investor fundraising for Commons Capital and Oxford Bioscience Partners for innovative healthcare investments for emerging and developing countries and was Senior Vice President, Group Head-Life Sciences for Comerica Bank. While at Comerica, notable deals included deals that led to several M&A exits including Hypnion/Eli Lilly; Adnexus/Bristol Meyers Squibb; and Morphotek/Eisai Pharmaceuticals.
Janice was President/CEO of the Massachusetts Biotechnology Council (MBC) which was at the forefront of the biotechnology revolution as the first biotechnology association in the world. Janice held senior managerial positions at Cambridge Medical Technology Corporation and Coopers & Lybrand Emerging Technology Group.
Janice is on several boards: Poxel Inc, The Village Bank, Commodore Builders, The Forsyth Institute, Emeritus Director of the MIT Koch Institute for Integrative Cancer Research Springboard Enterprises Life Science Council and is a member of Women on Corporate Boards and the Women's Forum. She is also active in Newton and serves as co-president of the Crystal Lake Conservancy and Board member of The Hyde Community Center. Janice is a trustee for a privately developed community home for differently-abled young working women and men.
She was named one of Boston Magazine's 100 most influential women and Newton Living Magazine's 10 most influential women.
Janice received her MBA degree in finance and accounting and her BS degree in veterinary science from the University of New Hampshire.
Job Titles:
- Biomedical Sciences & Associate Dean for Research, University of Nevada at Las Vegas
Job Titles:
- Legal Consultant, 5AM Venture Management, LLC Interim General Counsel, Jones & Vining
Karla Jarvis served as Senior Vice President, General Counsel & Secretary at The Rockport Group, a global footwear company headquartered in the Greater Boston Area. Karla was responsible for leading the company's global legal, compliance and HR functions and managing legal matters in domestic and international markets.
Prior to joining The Rockport Group in 2015, Karla was the Senior Vice President, General Counsel & Secretary of Clarks America, Inc., a subsidiary of a global footwear company, where she built the organization's legal department to support expansion into North, South and Central America. Karla played a key role in the company's SAP implementation, building a state-of-the art distribution center, developing the Corporate Social Responsibility Program and establishing a corporate foundation.
Karla holds a Bachelor degree from Clark University, a Master of Public Health from Boston University, and a Juris Doctorate from New England School of Law. She was born in Haiti and now resides in Watertown, MA with her husband and three children. She serves on the Board of Directors of Soles4Souls.
Job Titles:
- Deputy Scientific Director & Senior Investigator
Job Titles:
- Cofounder and General Partner at Flare Capital Partners
Job Titles:
- Vice President for Grant Strategy for CareQuest Institute for Oral
- Vice President for Grant Strategy, CareQuest Institute for Oral Health
Michael Monopoli, DMD, MPH, MS, serves as vice president for grant strategy for CareQuest Institute for Oral Health. In this role, Michael leads the organization's strategic philanthropic grantmaking activities to promote healthy communities and improve the overall system to create better oral health for all.
Michael leverages his expertise to collaborate with grantees and partners on a systems change approach to local, state, and national investment to strengthen communities and promote health equity. Prior to joining CareQuest Institute, Michael held a number of senior roles with the DentaQuest Partnership and Delta Dental of Massachusetts, an affiliate of CareQuest Institute. He also previously served as dental director at the Office of Oral Health for the Massachusetts Department of Public Health.
Michael is a past President of the American Association of Public Health Dentistry and is a Fellow of the American College of Dentists. He also serves on the boards of directors of the Forsyth Institute and the Cambridge Health Alliance Foundation. Michael serves on advisory councils of the Forsyth School of Dental Hygiene at the Massachusetts College of Pharmacy and Allied Health Sciences and the Massachusetts Department of Public Health.
Michael earned his Doctor of Dental Medicine degree from Tufts University School of Dental Medicine and two master's degrees from Harvard University Chan School of Public Health. He also completed a fellowship in geriatric dentistry at the Harvard School of Dental Medicine and the U.S. Department of Veterans Affairs.
Job Titles:
- Executive Director of Cedars
Executive Director of Cedars-Sinai Guerin Children's; Vice Dean for Children's Services; David and Meredith Kaplan Distinguished Chair in Children's Health; Professor of Pediatrics; Adjunct Professor of Orofacial Sciences and Pediatrics, UC San Francisco
Job Titles:
- President and CEO of LVCC, Inc
Job Titles:
- Vice President of Loomis, Sayles & Company
- VP, Strategic Relationship Manager Loomis, Sayles and Company, LP
Pamela Czekanski is a vice president of Loomis, Sayles & Company, and Strategic Relationship Manager. In this role, she works closely with sub-advised clients and helps provide solutions to the investment challenges they face.
Pam has over 30 years of experience managing equity and fixed income portfolios for institutional clients. After graduating with a BA in economics and concentration in music history from Middlebury College she went on to earn the Chartered Financial Analyst designation.
She has served as a Trustee of Middlebury, President of the Boston Middlebury Alumni Association and is currently a Trustee of the Bolton MA Public Library after serving as Co-Chair of the Library Construction Committee from 2006-2009. She has also served as a Mentor for the MiddCore experiential learning program at Middlebury.
Pam is a Director of the Forsyth Institute, where she is a member of the Finance and Investment Committees. She is also a member of the Boston Club promoting women in leadership, and a member of the Investment Committee for the Webb Institute.
Paula LaPalme joined Forsyth in 2016 and leads Human Resources for the Institute, as well as provides leadership to a host of key operational areas from information technology to facilities.
She is an ardent collaborator and contributor throughout Forsyth, working with others to create solutions and new paths. Paula serves on numerous committees and work teams ensuring Forsyth's culture, people practices, and programs are continuously innovating and advancing.
She has built an accomplished career as an HR executive, consultant and business leader. She has worked with both non-profit and for-profit organizations regionally, nationally and globally. Past associations include: The Boston Stock Exchange; Home Owners Savings Bank, F.S.B.; Tufts Health Plan; CGI; Logica; Philips/Color Kinetics; AMS; as well as her own consulting firm. The wealth of experience Paula brings from helping organizations successfully scale and evolve, to guiding them through the labyrinth of change is invaluable to Forsyth.
Paula holds a Bachelor's Degree in Business from Southern New Hampshire University, as well as HR certifications: SPHR, SHRM-SCP, and an HR Management Certification from Bentley University.
Job Titles:
- President of Nessen Associates, Ltd
Job Titles:
- Vice President, Global Personal Care, Global Home Care and Technology Strategy, Colgate Palmolive Company
Raj Kohli is responsible for leading the Colgate Palmolive Global Technology organization to drive innovation across the Personal Care and Home Care Categories. In addition, he is building the strategies and capabilities for Global Technology to deliver the future needs of the organization. This includes a comprehensive approach to deliver competitive innovations across eCommerce and further optimize the external search and adoption of new technology platforms.
Previously Raj was Vice President of Global Oral Care where he led groups including Product Development, Early Research, Clinical Research and Flavor Development. He drove renewed focus on Colgate's major toothpaste brands with powerful new technologies to deliver an innovation stream across multiple brands.
Raj joined Colgate in the United Kingdom in 1987 focused on the development of Personal Care products for the European Division. In 1993 he moved to the US to lead Global Oral Care Therapeutic Product Development where he oversaw the development of several new toothpastes and mouthwashes that were launched across the globe.
In 1997 Raj moved to India to design and set up a world class multifunctional Research Center, the first of its kind in the developing world for Colgate. In 2000 he was promoted to head up the Asia Global Research and Technology Centers, during which he oversaw the establishment of a center in China.
Job Titles:
- Investor
- Managing Director, Rubin / Anders
Richard Anders is an investor and long-time entrepreneur. He is the Founder and Managing Director of Mass Medical Angels, a leading life science angel group. He founded the legal software publishing company Jurisoft, which he sold to Lexis/Nexis, published newspapers including Boston Digital Industry and New York Digital Industry and currently serves as managing director of Rubin/Anders Scientific, which places scientists as consultants in patent projects. He has invested in approximately two dozen early-stage startups.
Richard is an overseer at the Museum of Science in Boston where he served as a trustee for nearly 20 years. At the museum he was most recently a member of the food committee, exploring science education around the issues of food and its preparation. He is a trustee of the Forsyth Institute and an overseer at the Brigham & Women's Hospital and the Gardner Museum. Richard founded and currently runs MA Medical Angels (MA2), one of the country's leading angel groups focused exclusively on life sciences. He has founded the angel group Launchpad, the nationally renowned Science on Screen event at the Coolidge Corner Cinema and was a founding trustee of the Massachusetts Interactive Media Council.
Over many years, he has served on numerous university grant and patent committees and was the life science advocate at Mass Challenge. He served for many years as a member of the Dana Farber Cancer Center Institutional Review Board. He has been a board member or board observer at multiple life science startups.
Richard teaches medical device entrepreneurship at the Harvard/MIT HST program. He is a graduate Summa Cum Laude in Mathematics from Harvard and holds a J.D. from Harvard Law School.
Richard currently serves on The Forsyth Institute's Patent Committee, Investment Committee and Finance Committee.
Job Titles:
- First Vice President
- First Vice President, Morgan Stanley Wealth Management
- Member of the Executive Committee of the Women 's Business Leaders Summit
Robyn Redfield is a first vice president, and senior portfolio manager at Morgan Stanley. Robyn is nationally recognized, most recently as a Forbes Magazine Top Women Wealth Advisor. She is responsible for providing investment consulting, asset allocation and investment management services to foundations, endowments, family offices and individuals.
Prior to joining Morgan Stanley in 1999, Robyn worked at Merrill Lynch as a financial advisor to individual investors, corporate executives and nonprofit organizations. She has also held management positions at Estee Lauder.
Robyn founded, and served as the chairwoman of the American Red Cross of Massachusetts Tiffany Circle. Created and launched by the National American Red Cross, the Tiffany Circle creates a network of women leaders who want to change lives, save lives and strengthen their local communities. Under her leadership, the Tiffany Circle has grown financially, and in the number of volunteers to support the local chapter of the American Red Cross of Eastern Massachusetts. She also serves on the board of directors of The American Red Cross, The Collette Foundation and Classics for Kids, as well as volunteering for other charities and nonprofit organizations to share experience and expertise.
Robyn holds a Bachelor of Science degree from the University of Bridgeport, and has a Certified Investment Management Analyst and CEC designation from the Wharton School, University of Pennsylvania.
Robyn is a member of the executive committee of the Women's Business Leaders Summit, which is sponsored by the U.S. State Department and held in Amman, Jordan.
Rosalee Hermens is the former Senior Vice President and Chief Information Officer of True Value Company, where she drives forward-thinking about new store technology and analytics.
Rosalee was influential in creating the company's strategic plan, providing an extensive and aggressive roadmap for growth fueled by technology. As part of executing the strategy, Rosalee is transforming IT on all levels - organizationally, technically and the portfolio of systems.
Job Titles:
- Chief Financial Officer
- Treasurer
- in 2022 As Chief Financial Officer
Sok Cheng Soh joined Forsyth in 2022 as Chief Financial Officer. Ms. Soh provides leadership for Forsyth's strategic and operational finance. She is a global finance executive with broad-based experience with both private and public companies. With an international career including assignments in Asia, Australia, and USA, Ms. Soh has led strategic initiatives to scale growth in complex and fast changing environments.
Job Titles:
- Executive Director of Biocom California
Stephanie Hsieh is executive director of Biocom California, a non-profit trade association for the life science industry, and a board member of Meditope Biosciences, Inc., a privately held preclinical stage immuno-oncology company.
Stephanie most recently served as CEO of Meditope Biosciences, growing the company from academic discovery to preclinical stage oncology, with a focused, yet diversified portfolio of immuno-therapy and oncology assets. In this capacity, Stephanie set strategic and commercial directions, securing the exclusive rights to the technology, as well as its Series A financing and pharma partnerships, and earned a reputation for operational excellence, including management of challenging P&Ls.
Job Titles:
- Director of Research and Faculty Affairs
After joining Forsyth in 2005 as a research scientist, Dr. Rittling brings her experience in grant writing and laboratory management to the position of Director of Research and Faculty Affairs. In this position, she facilitates all things research.
Job Titles:
- Vice President for Clinical and Translational
- Vice President for Clinical and Translational Research
Dr. Thomas Van Dyke is Vice President for Clinical and Translational Research and Chair of the Department of Applied Oral Sciences. He provides leadership for Forsyth's clinical research team and is responsible for expanding Forsyth's clinical presence in the research community. Dr. Van Dyke drives the Institute's efforts to expand Forsyth's connections to industry and corporate partners.
Dr. Van Dyke is a world-renowned leader in translational research. His clinical research team has focused largely on drug treatment for periodontitis and issues related to systematic diseases such as diabetes. He has broad connections with corporations and universities worldwide. Dr. Van Dyke joined Forsyth from Boston University where he was Professor, Department of Periodontology and Oral Biology, Boston University Goldman School of Dental Medicine; Program Director, Postdoctoral Periodontology; Director, Clinical Research Center, and Associate Director Boston University School of Medicine General Clinical Research Center.
Thomas E. Van Dyke received his dental degree in 1973 from Case Western Reserve University, Cleveland, OH, USA and a PhD in Oral Biology from State University of New York at Buffalo, NY in 1982. Dr. Van Dyke has published more than 350 papers in basic immunology related to inflammatory periodontal infections. Since 1995, Dr. Van Dyke's research has focused on the regulation of the innate immune response by active endogenous pathways.
He is a Diplomate of the American Board of Periodontology and he received the IADR Award for Basic Research in Periodontology in 2001 and the Norton Ross Award for Excellence in Clinical Research in 2002 among other honors and awards. He serves, or has served, on the editorial boards of Infection and Immunity, Journal of Periodontology, Journal of Periodontal Research, Journal of Clinical Periodontology, Journal of Dental Research, Journal of the International Academy of Periodontology, Oral Microbiology and Immunology, Journal of Public Health Dentistry, Current Opinions in Periodontology , Magazyn Stomatologiczy Dental Magazine, and he edited Periodontology 2000 Vols. 6 (1994) and 27 (2001). He served as President of the Periodontal Diseases Research Group of the IADR from 1991-1992. His other IADR/AADR service includes Membership Committee, 1983-1986, Science Information Committee, 1990-1993, and Scientific Awards Committee, 2001-2006. Dr. Van Dyke has also served as President of the International Academy of Periodontology (1997-1999).
Dr. Van Dyke has authored/co-authored 350+ original articles, and numerous abstracts and book chapters. He is a member of the American/International Association of Dental Research, American Academy of Periodontology, American Association for the Advancement of Science, American Association of Immunologists, American Dental Association, American Society of Microbiology, International Academy of Periodontology, IADR Periodontal Research Group, International Endotoxin and Innate Immunity Society, Northeast Periodontal Society, and Society for Leukocyte Biology. His research interests are the structural and functional relationship of abnormalities of the inflammatory process with focus on regulation of phagocytic cells, in the etiology and pathogenesis of periodontal diseases. He is best known for his work on the pathways of resolution of inflammation and pathogenesis of periodontal diseases, neutrophil biology, and clinical research.
Job Titles:
- Oral and Maxillofacial Surgery and Harvard University Distinguished Service Professor, Harvard School of Dental Medicine
Dr. R. Bruce Donoff, Walter C. Guralnick Distinguished Professor of Oral and Maxillofacial Surgery and Harvard University Distinguished Service Professor, served as Dean of Harvard School of Dental Medicine (HSDM) from 1991-2019. He was born in New York City, and attended Brooklyn College as an undergraduate. He received his DMD from the Harvard School of Dental Medicine in 1967 and his MD from Harvard Medical School in 1973. Dr. Donoff's professional career has centered on Harvard's Faculty of Medicine and the Massachusetts General Hospital's Department of Oral and Maxillofacial Surgery. He began as an intern in 1967, served as Chairman and Chief of Service from 1982 through 1993, and continues to see patients today.
In addition to leading HSDM as its Dean, Dr. Donoff has made major contributions in research to the specialty of oral and maxillofacial surgery with interests in wound healing, bone graft survival, sensory nerve repair and oral cancer. He has published over one hundred papers, authored textbooks, and lectured worldwide. He recently helped launch the HSDM Initiative - Integrating Oral Health and Medicine, a project of great importance to him. Dr. Donoff served twelve years on the Board of the Oral and Maxillofacial Surgery Foundation and is former President of the Friends of the National Institute of Dental and Craniofacial Research. He is the editor of the MGH Manual of Oral and Maxillofacial Surgery and a member of the Editorial Board of the Journal of Oral and Maxillofacial Surgery and the Massachusetts Dental Society Journal.
Job Titles:
- Chairman of the Board, Program in Cellular and Molecular Medicine / Immune Disease Institute
Walter Pressey is Chairman of the Board, Program in Cellular and Molecular Medicine / Immune Disease Institute, a non-profit medical research firm affiliated with the Harvard Medical School and Children's Hospital in Boston.
For over fourteen years, he held the position of President and Vice Chairman, CFO of Boston Private Financial Holdings, a wealth management company.